Startup fills growing drug-trial niche: Indianapolis-based Anaclim focuses on recruiting minority patients
A new Indianapolis company plans to attack the chronic shortage of minority patients in drug trials armed only with 11 employees and the wisdom of a couple Eli Lilly and Co. executives. However, the founders of Anaclim believe they’ll find ample success by focusing exclusively on the growing push for diversity in the $10 billion contractresearch industry. Anaclim, which occupies a mostly empty office at Intech Park, could double its staff quickly and start raking in eight-figure revenue within three…